Our work suggests that in SPRY2‐deficient tumours IL6 may mediate AR‐dependent CRPC formation by facilitating tumoral androgen biosynthesis, at least in part through enhanced androgen biosynthesis. The gene discussed is AR; the disease is neoplasm.